Featured

Top 100 Global Innovators for 2023 revealed [Report]

Ed White

Principal Analyst and VP

arrow_forward Read more
Biopharma
The Drugs to Watch in 2023
arrow_forward Read more
Academia and Government
Highly Cited Researchers 2022: Using deeper qualitative analysis to help spot research misconduct
arrow_forward Read more
Life Sciences and Healthcare
May 31, 2023

Pharma-biotech partnerships take on new urgency as patent cliffs loom
Intellectual Property
May 31, 2023

Celebrating women in IP: Meet our expert Sandra Mau
Clarivate Insights
May 30, 2023

Why the rise of intellectual property value means IP leaders need better budget management
Esmaeil Khaksari
Senior Director, Product Management
Clarivate
Intellectual Property
May 24, 2023

Celebrating women in IP: Meet our expert Ronda Majure
Life Sciences and Healthcare
May 24, 2023

Gene therapies transform rare disease treatment: hope for patients amidst regulatory, payer and developer challenges
Matthew Arnold
Principal Analyst
Clarivate
Clarivate Insights
May 22, 2023

How Clarivate uses Artificial Intelligence you can trust to transform your world
Bill Graff
Chief Information Officer
Clarivate
Academia and Government
May 18, 2023

Building trust through transparency: Our pledge to provide more clarity around Web of Science journal coverage
Dr Nandita Quaderi
Editor-in-Chief & Vice President, Web of Science
Clarivate
Clarivate Insights
May 18, 2023

Advancing our commitments to global sustainability [Report]
Marko Damjanovic
Head of Corporate Sustainability
Clarivate
Life Sciences and Healthcare
May 11, 2023

Mainland China’s regulatory evolution brings greater access to novel drugs
Ruchita Kumar, Ph.D.
Senior Manager, Healthcare Research & Data Analytics, China In-Depth
Clarivate
Intellectual Property
May 10, 2023

Celebrating women in IP: Meet our expert Jill Power
Life Sciences and Healthcare
May 8, 2023

Building a business through economic uncertainty: tales from the biotech trenches
Intellectual Property
May 3, 2023

Celebrating women in IP: Meet our expert Rosemary Bassilakis
Intellectual Property
May 1, 2023

Patent filings and translations: Decreasing costs while improving productivity
Clarivate Insights
April 27, 2023

Think forward
Jonathan Gear
CEO
Clarivate